Acquisition of Intravenous Stable Isotopes
Closed Pre-Solicitation Posted
- Solicitation number
- 75N94024Q00264
- Agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
Summary of the Pre-Solicitation Notice:
The National Institutes of Health, National Institute of Child Health and Human Development is seeking to procure intravenous stable isotopes, specifically 6,6 deuterated glucose and d5 glycerol, for metabolic research through a non-competitive contract award. The government intends to award a purchase order to Pine Pharmaceuticals LLC under simplified acquisition procedures without full and open competition, as Pine Pharmaceuticals is the only approved source for these specialized isotopes. The contract will cover the procurement of raw materials, production, and testing of the isotope products. The period of performance is from September 16, 2024 to September 15, 2025, with deliveries required by December 31, 2024. Interested parties may respond with information demonstrating their capabilities by September 12, 2024, but the government will make the sole-source award determination.
This procurement is not set aside and does not have a designated small business category. Pine Pharmaceuticals LLC is the current incumbent contractor for these isotopes. The value of the contract is not specified, but the government is seeking to acquire the required quantities of 6,6 deuterated glucose and d5 glycerol for the National Institute of Digestive, Diabetes & Kidney Diseases' metabolic research needs during the performance period.
Notice text
SEE ATTACHED.
Files
| File | Type | Posted |
|---|---|---|
| PINE PHARMACEUTICALS LLC.NOTICE OF INTENT.75N94024Q00264.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Stability Testing for ManNAc Drug Product produced in Campaigns 5 and 6. Stability testing will occur under regulatory compliance | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity